newsfilter
← Latest News
GlobeNewswire·

Adagio Therapeutics to Participate in Upcoming Investor Conferences

WALTHAM, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (NASDAQ:ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with p